New cancer clinical trial: Hepatic Impairment Study for Lorlatinib in Cancer Patients

Published on: October 31, 2018 at 12:00PM
Condition:   Advanced Cancers
Intervention:   Drug: lorlatinib
Sponsor:   Pfizer
Not yet recruiting
https://ift.tt/2PtzBwv